当前,人工角膜内移植在成人无晶状体患者中进行临床试验,对治疗严重近视与远视患者正进行临床评价。据制造厂商说,这种人工角膜凝胶镜片(Kerato-Gellens)是用来代替供者组织的植入物。该公司发言人Kay Ford说,美国每年约有120万人因行白内障手术成为无晶状体者;少数人因事故失去晶状体,其中大多数患者施行 Currently, artificial intracorneal transplantation in adult patients with aphakia clinical trials, the treatment of patients with severe myopia and hyperopia are undergoing clinical evaluation. According to the manufacturer, this Kerato-Gellens is an implant used to replace donor tissue. Kay Ford, a spokesman for the company, said that in the United States, about 1.2 million people a year become cataract-free due to cataract surgery. A small number of people lose their lenses due to an accident, and most of them are administered